pediatr
gastroenterolog
j
richard
hamilton
md
frcpc
twenti
year
ago
even
sophist
diagnost
facil
could
identifi
caus
acut
diarrhea
per
cent
less
case
childhood
figur
approach
per
cent
far
import
factor
contribut
remark
improv
diagnost
success
recognit
human
rotaviru
major
caus
acut
diarrhea
young
children
viral
bacteri
enter
pathogen
man
identifi
two
decad
understand
mechan
infect
caus
diarrhea
improv
greatli
new
knowledg
provid
sound
basi
impress
advanc
activ
therapi
promis
approach
prevent
problem
annual
kill
nearli
million
young
children
mrica
latin
america
asia
exclud
china
articl
review
current
concept
mechan
manag
viral
enter
focu
rotaviru
diarrhea
relev
experiment
model
risk
make
gener
comment
subject
global
impact
viral
enteritid
acknowledg
certainli
major
region
differ
exist
manifest
implic
ill
base
host
genet
environment
factor
strike
develop
develop
countri
compar
author
direct
exposur
problem
occur
primarili
former
environ
furthermor
articl
place
emphasi
pathophysiolog
event
reflect
author
background
rather
rel
import
major
contribut
made
field
rang
disciplin
includ
virolog
veterinari
medicin
epidemiolog
public
health
whatev
perspect
recent
histori
viral
enter
view
excit
fascin
stori
reveal
reassur
note
day
gone
wise
clinician
said
confront
young
child
acut
wateri
diarrhea
pediatr
clinic
north
americavol
viru
correctusu
actual
said
colleagu
veterinari
medicin
deal
devast
global
problem
scour
young
farm
anim
case
young
child
usual
viral
pathogen
rotaviru
sever
virus
list
tabl
known
capabl
caus
diarrhea
mani
agent
character
complet
uncertainti
disagr
continu
nomenclatur
one
hope
terminolog
follow
keep
consensu
view
rna
virus
distinct
structur
import
best
character
human
viral
pathogen
rotaviru
particl
consist
outer
inner
capsid
surround
central
core
contain
nucleic
acid
perhap
appar
prefer
differenti
villu
enterocyt
dome
epithelium
overli
peyer
patch
virus
difficult
adapt
cell
cultur
infect
cell
viral
particl
appear
first
fine
granular
cytoplasm
area
later
distend
cisterna
endoplasm
reticulum
probabl
segment
doubl
strand
rna
rotaviru
genom
littl
known
cell
surfac
receptor
rotavirus
specif
seem
direct
cell
type
speci
infect
villu
epithelium
small
intestin
region
gut
organ
respiratori
urinari
tract
human
strain
grown
calv
piglet
anim
obvious
compar
experi
conduct
man
unlik
reservoir
human
pathogen
found
anim
kingdom
four
distinct
serotyp
human
rotaviru
base
viral
neutral
test
two
occur
anim
serotyp
emerg
frequent
identifi
agent
human
case
relationship
virul
host
resist
geograph
distribut
serotyp
clear
rotaviru
serum
antibodi
detect
per
cent
studi
differ
part
world
extent
immun
respons
protect
known
sequenti
infect
differ
strain
occur
child
also
children
combin
immun
defici
experi
seriou
difficulti
shed
viru
agent
report
first
ruth
bishop
melbourn
colleagu
show
duoden
lesion
associ
viral
invas
intestin
epithelium
massiv
fecal
excret
viru
acut
diseas
convalesc
shortli
infect
human
volunt
immun
fluoresc
studi
show
diffus
involv
upper
intestin
villu
epithelium
report
studi
found
close
relationship
rotaviru
excret
acut
diarrhea
infant
howev
report
franc
signific
number
asymptomat
children
shown
excret
viru
stool
perth
australia
question
diagnost
mean
rotaviru
sight
stool
certain
popul
anoth
intrigu
observ
made
sever
center
yet
fulli
explain
fecal
excret
rotaviru
particl
asymptomat
newborn
infant
spread
human
rotaviru
enter
humantohuman
presum
fecalor
hardi
viru
impress
retain
virul
long
shed
evidenc
appar
capac
induc
nosocomi
infect
long
period
hospit
furnitur
wall
floor
commun
least
temper
climat
winter
season
incid
strike
unexplain
small
round
virus
srv
norwalk
viru
identifi
outbreak
norwalk
ohio
viru
best
character
srv
observ
acut
diarrheal
stool
proof
norwalk
agent
pathogen
man
come
identif
epidem
diarrheal
stool
document
serolog
respons
acut
infect
transmiss
human
volunt
small
particl
virion
contain
simpl
structur
protein
dalton
nucleic
acid
content
known
like
rotaviru
norwalk
agent
seem
invad
upper
intestin
mucosa
caus
histolog
lesion
infect
volunt
howev
tini
particl
identifi
duoden
tissu
volunt
b
shi
larg
group
virus
share
certain
featur
attribut
norwalk
agent
morpholog
classifi
featureless
structur
group
see
tabl
associ
gastroenter
structur
group
better
support
featureless
group
fact
except
norwalk
agent
hard
evid
confirm
pathogen
virus
tenuou
srv
similar
size
assess
buoyant
densiti
observ
stool
acut
diarrheal
ill
usual
cours
epidem
less
quantiti
rotavirus
caliciviru
distinct
star
structur
astroviru
star
surfac
latter
two
member
group
one
propag
cell
cultur
date
biochem
genet
character
srv
remain
incomplet
agent
associ
gastroenter
children
year
suggest
strong
relationship
aris
recent
electronmicroscop
studi
stool
similar
size
rotaviru
adenovirus
distinct
icosahedr
morpholog
radioimmunoassay
enzym
immunoassay
system
help
identifi
infect
adenovirus
may
common
caus
acut
diarrhea
claim
identifi
per
cent
stool
includ
asymptomat
control
pleomorph
envelop
rna
virus
possess
characterist
fring
radiat
project
human
strain
propag
fetal
intestin
organ
cultur
cell
cultur
long
recogn
caus
acut
diarrhea
anim
exampl
transmiss
gastroenter
piglet
identifi
patient
diarrhea
mani
region
world
definit
studi
establish
pathogen
lack
still
pattern
symptom
experienc
young
child
respons
first
exposur
human
rotaviru
rather
consist
sever
symptom
impact
child
vari
greatli
depend
mani
variabl
includ
extent
intestin
lesion
resist
reserv
host
within
two
day
exposur
low
grade
fever
anorexia
usual
vomit
last
hour
wateri
diarrhea
cramp
begin
second
day
last
day
fecal
output
massiv
caus
rapid
even
fatal
dehydr
acidbas
dysequilibrium
physic
sign
dehydr
loss
bodi
weight
decreas
skin
turgor
sunken
fontanel
eye
may
develop
one
awar
diarrhea
wateri
stool
may
pool
bowel
lumen
may
confus
urin
diaper
acut
phase
ill
auscult
abdomen
reveal
hyperact
bowel
sound
sever
difficult
evalu
rectal
examin
particularli
help
provid
instantan
assess
consist
amount
stool
examin
fece
usual
reveal
littl
blood
cellular
exud
may
reduc
substanc
typic
diseas
follow
selflimit
cours
day
diarrhea
settl
sixth
day
sooner
subsequentlya
gradual
return
normal
appetit
activ
laboratori
data
sever
affect
patient
show
rais
fecal
na
concentr
isoton
dehydr
reduc
plasma
bicarbon
level
sever
affect
child
particularli
infant
may
develop
lethal
hypernatremia
hyponatremia
mark
acidosi
child
receiv
hyperosmolar
drink
commerci
beverag
gelatin
water
fruit
juic
undilut
solut
high
salt
content
certain
commerci
prepar
soup
milk
boil
extend
time
likelihood
ofhypernatremia
increas
standard
hematolog
indic
may
distort
dehydr
case
serum
transaminas
activ
increas
slightli
electron
microscop
identif
viru
stool
acut
diarrhea
still
effect
diagnost
techniqu
enzymelink
immunoassay
elisa
revers
passiv
hemagglutin
techniqu
develop
sensit
rel
inexpens
altern
cours
none
techniqu
distinguish
differ
serotyp
speci
viru
case
rise
serum
antibodi
titer
rotaviru
measur
acut
attack
although
infant
vulner
diseas
symptom
newborn
infant
mild
absent
presenc
fecal
viru
excret
one
studi
per
cent
newborn
babi
excret
viru
diarrhea
observ
explain
complet
protect
effect
matern
milk
feed
observ
non
breast
fed
babi
control
trial
supplement
oral
feed
human
gamma
globulin
protect
young
infant
infect
diseas
adult
rotaviru
rare
caus
sever
diarrhea
usual
symptom
less
sever
children
presum
almost
previous
develop
immun
respons
infect
impress
gain
studi
famili
contact
young
patient
experi
resid
physician
newli
arriv
children
hospit
nausea
anorexia
cramp
persist
day
diarrhea
infrequ
brief
elderli
may
sever
symptom
young
adult
judg
limit
observ
elderli
rel
affect
infant
howev
age
unlik
come
close
contact
infect
babi
frequent
norwalk
norwalklik
agent
clinic
featur
infect
common
adult
children
document
care
adult
malais
fever
nausea
abdomin
cramp
follow
within
hour
vomit
promin
featur
diarrhea
occur
case
norwalk
epidem
per
cent
affect
individu
suffer
signific
vomit
per
cent
diarrhea
rare
infect
caus
signific
dehydr
stool
wateri
contain
neither
leukocyt
blood
clinic
featur
group
infect
seem
indistinguish
one
appear
major
pathogen
young
children
viral
excret
stool
detect
onset
symptom
hour
techniqu
use
identifi
viru
includ
electron
microscopi
immunoelectron
microscopi
norwalk
viru
radioimmunoassay
immun
adher
hemagglutin
assay
relationship
virus
gastrointestin
symptom
tenuou
allow
authorit
descript
associ
clinic
manifest
point
clinic
signific
diarrhea
attribut
adenoviru
associ
agent
intussuscept
report
earlier
substanti
crampi
pain
promin
clinic
featur
virus
isolatd
stool
associ
epidem
diarrhea
symptom
rel
mild
usual
wateri
diarrhea
cramp
vomit
confin
less
hour
rotavirus
invad
epithelium
small
intestin
involv
proxim
portion
extend
diffus
involv
much
entir
small
bowel
studi
rabbit
show
earli
heavi
invas
peyer
patch
region
rotaviru
suggest
possibl
prefer
portal
entri
extens
villu
epitheli
crypt
epitheli
invas
infect
stomach
colon
anim
studi
invas
surfac
epithelium
small
intestin
gener
prolif
respons
crypt
mark
increas
epitheli
renew
rate
consequ
viru
shed
epithelium
becom
domin
cell
migrat
quickli
crypt
fail
undergo
normal
process
differenti
diarrhea
seem
result
direct
viral
damag
subsequ
poorli
differenti
statu
bowel
mayor
may
structur
lesion
shorten
villi
reduc
surfac
area
present
undoubtedli
contribut
function
compromis
norwalk
agent
identifi
mucosa
caus
lesion
upper
intestin
similar
seen
rotaviru
diseas
presum
virus
group
true
pathogen
interact
mucosa
similar
case
candid
viral
pathogen
invas
mucosa
gut
establish
current
understand
mechan
viral
diarrhea
base
mainli
studi
corona
viru
enter
piglet
transmiss
gastroenter
tge
reproduc
ill
ident
produc
piglet
hrv
although
two
virus
differ
interact
small
intestin
seem
ident
height
oftg
diarrhea
sever
function
abnorm
identifi
could
contribut
excess
fecal
salt
water
loss
brush
border
membran
disaccharidas
activ
decreas
function
basolater
membran
na
pump
nakatpas
system
domin
transport
defect
appear
mark
reduct
na
gradientdepend
glucos
absorpt
across
intestin
brush
border
neutral
naci
absorpt
site
decreas
also
absenc
function
high
affin
brush
border
membran
glucos
carrier
seem
contribut
diminish
nafacilit
glucos
absorpt
interest
alaninena
co
transport
may
partial
impair
acut
viral
diarrhea
furthermor
evid
intracellular
accumul
cyclic
amp
gmp
evid
activ
secretori
process
one
would
encount
cholera
believ
function
profil
small
intestin
acut
tee
diarrhea
keep
current
concept
profil
normal
intestin
crypt
cell
function
appli
rotaviru
enter
tee
enter
viru
shed
mucosa
time
diarrhea
becom
sever
relationship
may
appli
fulli
rotaviru
diseas
rotaviru
continu
shed
stool
acut
diarrhea
fed
patient
rotaviru
tee
stool
contain
concentr
na
ci
mg
per
l
higher
normal
much
less
seen
secretori
state
like
cholera
find
compat
function
defect
describ
recoveri
depend
sever
process
describ
rapid
turnov
epithelium
combin
peristals
activ
act
clear
superfici
infect
gut
rel
import
process
increas
mucin
secret
immun
globulin
known
recoveri
epithelium
matter
replac
shed
cell
also
restor
function
differenti
epithelium
wellnourish
host
repair
process
usual
complet
day
probabl
regul
cell
prolifer
crypt
migrat
cell
onto
villi
somewhat
distinct
factor
control
differenti
cell
migrat
rang
hormon
neuropharmacolog
factor
influenc
process
direct
relev
clinic
issu
yet
elucid
may
chronic
undernutrit
host
alter
suscept
shed
malnutrit
also
expect
alter
intestin
repair
process
much
learn
chronic
proteincalori
undernutrit
mani
clinic
anim
model
reduc
activ
cell
prolifer
gut
anim
tl
postnat
develop
function
repair
acut
experiment
viral
enter
shown
delay
role
micronutri
might
play
observ
yet
known
seem
nutrit
deplet
must
rel
sever
signific
effect
repair
intestin
epithelium
note
effect
prevent
measur
alway
avail
proof
diseas
realli
contagi
mere
reaffirm
crucial
import
breast
feed
hygien
measur
reduc
incid
sever
avail
evid
support
view
breast
feed
reduc
incid
sever
acut
infantil
diarrhea
mechan
protect
influenc
clear
rotaviru
antibodi
found
human
milk
iga
antibodi
link
secretori
piec
expect
resist
intralumin
proteolysi
spread
infect
fecalor
person
hygien
water
suppli
sewag
control
food
prepar
potenti
import
consider
rotavirusinfect
subject
gener
contamin
environ
provid
potent
sourc
oral
contamin
shell
fish
shown
harbor
norwalk
viru
caus
epidem
acut
vomit
diarrhea
particular
import
pediatr
nosocom
spread
rotaviru
particular
enter
virus
agent
appear
extrem
hardi
rigor
hygien
care
clean
institut
furnitur
equip
import
prevent
measur
children
must
admit
hospit
high
likelihood
per
cent
infant
develop
viral
enter
admit
modern
hospit
particularli
winter
anoth
reason
avoid
admiss
possibl
prepar
effect
safe
vaccin
hamper
fact
agent
reliabl
propag
tissu
cultur
therefor
rapid
emerg
two
group
rotaviru
vaccin
subject
clinic
test
remark
vaccin
attenu
live
viru
prepar
one
calf
viru
other
simian
virus
earli
control
field
trial
bovin
strain
vaccin
finnish
children
show
protect
subsequ
ongo
larg
scale
trial
develop
region
less
conclus
intens
research
attent
focus
simian
strain
trial
caus
febril
respons
third
fourth
day
vaccin
high
rate
infect
signific
protect
shown
limit
trial
simian
virus
present
vaccin
proven
safeti
efficaci
avail
signific
progress
made
toward
object
fluid
electrolyt
applic
modern
pathophysiolog
principl
fluid
therapi
diarrhea
one
import
medic
advanc
centuri
oral
fluid
therapi
stimul
earli
day
elucid
mechan
cholerainduc
secret
dramat
impact
surviv
morbid
diarrheal
diseas
glucoseelectrolyt
solut
prepar
oral
rehydr
therapi
ort
promot
diarrheal
diseas
program
unicef
sinc
shown
effect
rehydr
per
cent
case
diarrheal
dehydr
mani
might
otherwis
need
intraven
fluid
child
secretori
bacteri
toxininduc
diarrhea
exampl
escherichia
coli
cholera
solut
theoret
promot
absorpt
glucos
facilit
na
absorpt
compens
secretori
loss
child
viral
diarrhea
provid
balanc
equimolar
glucos
na
mixtur
ion
isoton
solut
make
best
possibl
use
absorpt
capac
remain
sick
intestin
import
recogn
solut
lessen
diarrhea
directli
provid
signific
nutrit
child
maintain
fluid
balanc
case
brief
period
transient
diseas
rare
case
viral
diarrhea
entir
length
small
intestin
involv
oral
fluid
may
insuffici
intraven
fluid
may
requir
particularli
young
patient
littl
function
reserv
oral
fluid
therapi
effect
safe
premix
cachet
cheap
easi
distribut
wide
measur
alon
strike
impact
luanda
angola
pediatr
hospit
decreas
diarrhea
death
per
cent
observ
mani
center
reduct
per
cent
occur
develop
countri
partli
rel
easi
access
intraven
fluid
partli
fact
problem
less
devast
also
entrench
pattern
care
slow
respons
commerci
supplier
oral
rehydr
therapi
use
lag
behind
develop
countri
howev
econom
argument
document
eas
safeti
techniqu
time
slowli
win
day
discuss
continu
focu
ideal
formul
oral
rehydr
therapi
formul
undoubtedli
effect
safe
best
avail
solut
use
develop
region
sever
diseas
nutrit
deplet
preval
reduct
sodium
chlorid
concentr
approxim
half
concentr
mm
per
l
seem
alter
efficaci
solut
studi
american
trial
fact
recommend
feed
equal
volum
water
oral
rehydr
solut
or
treat
young
babi
mani
commerci
product
distribut
develop
countri
constitut
na
concentr
meq
per
l
similar
stool
acut
viral
diarrhea
sever
modif
or
consid
base
recent
pathophysiolog
studi
clinic
trial
amino
acid
least
alanin
enhanc
na
absorpt
presenc
glucos
na
cotransport
may
partial
preserv
acut
viral
diarrhea
one
approach
supplement
or
amino
acid
earli
promis
recent
evalu
glycin
supplement
shown
signific
benefit
amino
acid
dipeptid
assess
encourag
use
oral
rehydr
solut
base
cook
indigen
food
rice
base
or
use
initi
effort
develop
cheap
avail
product
shown
reduc
stool
output
acut
diarrhea
mechan
respons
may
relat
content
amino
acid
peptid
mixtur
avail
solut
actual
reduc
stool
volum
attract
beyond
obviou
direct
impact
patient
fluid
balanc
solut
would
gain
much
enthusiast
accept
current
avail
reduc
diarrhea
rememb
improv
or
mixtur
contribut
significantli
patient
nutrient
intak
nutrit
treatment
current
trend
encourag
earli
feed
patient
support
recent
acquir
pathogenet
data
renew
differenti
small
intestin
epithelium
crucial
develop
recoveri
viral
diarrhea
vulner
proteincalori
malnutrit
particularli
young
epidemiolog
data
pakistan
indic
averag
durat
symptom
rel
extend
among
malnourish
patient
earlier
limit
clinic
trial
show
deleteri
impact
diarrhea
improv
nutrit
statu
children
fed
earli
cours
infecti
diarrhea
extens
studi
question
progress
margin
patient
nutrit
statu
onset
enter
infect
import
earli
feed
becom
concern
express
earli
ingest
dietari
protein
may
predispos
patient
allerg
reaction
gut
theoret
antigen
entri
across
infect
mucosa
could
enhanc
trigger
hypersensit
reaction
gut
view
clinician
sequenc
event
occur
milk
feed
data
intact
protein
transport
acut
experiment
viral
enter
show
vitro
increas
absorpt
earli
invas
phase
viral
infect
vivo
studi
intact
anim
show
enhanc
protein
uptak
viral
diarrhea
recent
studi
heyman
associ
use
germfre
mous
model
protein
absorpt
enhanc
earli
rotaviru
infect
introduct
enter
bacteria
greatli
increas
intact
protein
absorpt
immunolog
signific
observ
uncertain
studi
earli
feed
shown
increas
occurr
sensit
reaction
anoth
consider
nutrit
manag
viral
enter
capac
infect
intestin
deal
dietari
disaccharid
particularli
lactos
although
clinic
experiment
studi
lactas
activ
significantli
diminish
rel
rare
encount
lactos
intoler
convalesc
except
seem
among
aborigin
peopl
lactos
poorli
toler
even
health
especi
face
small
intestin
diseas
drug
pharmacolog
agent
shown
place
treatment
acut
viral
diarrhea
effort
continu
search
drug
may
revers
mechan
contribut
transport
defect
describ
influenc
process
cell
differenti
central
process
agent
enhanc
absorpt
vitro
either
ineffect
toxic
vivo
antidiarrh
drug
continu
promot
use
young
children
alter
fecal
volum
significantli
alter
peristalsi
time
appear
chang
output
potenti
hazard
rotaviru
emerg
major
enter
pathogen
caus
acut
diarrhea
young
children
throughout
world
viral
pathogen
recogn
addit
candid
agent
suspect
none
approach
rotaviru
global
impact
strong
appropri
emphasi
place
prevent
therapi
although
vaccin
yet
avail
clear
improv
hygien
practic
particularli
pediatr
institut
breast
feed
much
prevent
seriou
ill
earli
month
babi
vulner
past
decad
clinic
studi
anim
model
much
learn
pathogenesi
rotaviru
diarrhea
find
provid
